|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C12Q 1/00 | |||
| C07K 16/22 | |||
| A61K 45/06 | |||
| C12Q 1/68 | |||
| G01N 33/574 |
| (11) | Number of the document | 2802346 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13736138.2 |
| Date of filing the European patent application | 2013-01-11 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/021306 |
| Date | 2013-01-11 |
| (87) | Number | WO 2013/106765 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261586660 P | 2012-01-13 | US |
| (72) |
BAIS, Carlos, US
BRAUER, Matthew, US
SCHMIDT, Maike, US
SINGH, Mallika, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS |
| BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS |